A Randomized, Open-Label, Multicenter Study of Liposomal Amikacin for Inhalation (LAI) in Adult patients with nontuberculous Mycobacterial (NTM) Lung Infections caused by Mycobacterium aviumcomplex (MAC) that are refractory to treatment
Status
NOT RECRUITING
Investigator(s)
Stephen Ruoss